5IVZ
Cetuximab Fab in complex with Arg8Cir meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2011-08-17 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.340, 82.570, 212.050 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 34.290 - 2.480 |
R-factor | 0.1788 |
Rwork | 0.176 |
R-free | 0.22980 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.007 |
RMSD bond angle | 0.916 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX ((1.10_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 34.290 | 2.540 |
High resolution limit [Å] | 2.480 | 2.480 |
Number of reflections | 40202 | |
<I/σ(I)> | 38.2 | 11.4 |
Completeness [%] | 98.2 | |
Redundancy | 6.2 | 4.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citric acid, 0.1 M sodium phosphate dibasic, 0.4 M potassium phosphate dibasic, 1.6 M sodium phosphate monobasic |